KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Taxes (2016 - 2022)

Fulgent Genetics (FLGT) has disclosed Current Taxes for 6 consecutive years, with $426000.0 as the latest value for Q3 2022.

  • Quarterly Current Taxes fell 97.62% to $426000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $426000.0 through Sep 2022, down 97.62% year-over-year, with the annual reading at $787000.0 for FY2021, 98.52% down from the prior year.
  • Current Taxes hit $426000.0 in Q3 2022 for Fulgent Genetics, down from $2.8 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $120.5 million in Q1 2021 to a low of $24000.0 in Q4 2019.
  • Historically, Current Taxes has averaged $24.1 million across 4 years, with a median of $8.7 million in 2020.
  • Biggest five-year swings in Current Taxes: skyrocketed 222062.5% in 2020 and later crashed 98.52% in 2021.
  • Year by year, Current Taxes stood at $24000.0 in 2019, then surged by 222062.5% to $53.3 million in 2020, then crashed by 98.52% to $787000.0 in 2021, then plummeted by 45.87% to $426000.0 in 2022.
  • Business Quant data shows Current Taxes for FLGT at $426000.0 in Q3 2022, $2.8 million in Q2 2022, and $52.2 million in Q1 2022.